Caron A. Jacobson, MD, MMSc

Caron A. Jacobson, MD, MMSc, is an assistant professor of medicine at Harvard Medical School and a member of the Lymphoma Group at Dana-Farber Cancer Institute. She is the medical director of the Immune Effector Cell Therapy Program at Dana-Farber, overseeing the multidisciplinary efforts in chimeric antigen receptor T-cell, engineered T-cell receptor T-cell, and natural killer cell therapies across hematologic malignancies and solid tumors.

Dr Jacobson is board certified in hematology, internal medicine, and medical oncology. She treats patients with lymphoma and oversees clinical trials in B-cell non-Hodgkin lymphoma. She participates in and runs industry-sponsored and investigator-initiated trials. Most of Dr Jacobson’s research is focused on engineered and chimeric antigen receptor T-cell therapies.